Home » Science and Research » 3 to watch

Category: 3 to watch

January 4, 2024 STAT Off 3 to watch, artificial intelligence, Biotech, Health Tech, Human Health, Life Sciences, Medicine, Science and Research, STAT+

Health tech hopefuls might once have been used to a wealth of job options, especially…

January 3, 2024 STAT Off 3 to watch, artificial intelligence, Biotech, Health Tech, hospitals, Human Health, Life Sciences, Medicine, Science and Research, STAT+

Hospitals and clinics are expecting a slightly better 2024 compared to last year thanks to…

December 28, 2023 STAT Off 3 to watch, Biotech, biotechnology, drug prices, health care policy, health insurance, hospitals, Human Health, Life Sciences, Medicine, Pharmaceuticals, Politics, Science and Research, STAT+, states

For most states, the new year means a new legislative session. STAT’s taking a look…

December 27, 2023 STAT Off 3 to watch, Biotech, biotechnology, FDA, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, policy, Politics, Science and Research, STAT+, White House

WASHINGTON — The Food and Drug Administration has a lot on its plate in 2024…

December 27, 2023 STAT Off 3 to watch, Biotech, drug pricing, Human Health, Life Sciences, Medicine, obesity, Pharma, Pharmaceuticals, Pharmalot, Science and Research, STAT+

As another year comes to an end and the world seems to hit the proverbial…

December 26, 2023 STAT Off 3 to watch, Biotech, finance, health care policy, Health Tech, Human Health, Life Sciences, medical devices, Medicine, Science and Research, startups, STAT+

It’s been a slow year for medtech. Major deals in 2023 were scarce, funding was…

December 22, 2023 STAT Off 3 to watch, Biotech, climate change, COVID-19, global health, Health, Human Health, infectious disease, Life Sciences, Medicine, Science and Research

As we enter the fifth year of this challenging decade, life finally appears to be…

December 20, 2023 STAT Off 3 to watch, Biotech, biotechnology, CRISPR, Human Health, Life Sciences, Medicine, obesity, Science and Research, STAT+

Every winter, like Punxsutawney nobles, biotech’s many thought leaders gather in San Francisco to pick…

January 5, 2023 STAT Off 3 to watch, Biotech, CMS, Congress, drug pricing, HHS, Human Health, Joe Biden, Life Sciences, Medicare, Medicine, Pharma, policy, Politics, Science and Research, STAT+, White House

WASHINGTON — The legislative saga on drug pricing is mostly over for now, but drug…

January 4, 2023 STAT Off 3 to watch, Biotech, coronavirus, global health, Health, Human Health, infectious disease, Life Sciences, Medicine, public health, Science and Research

For the first two years of the Covid-19 pandemic, people working in the infectious diseases…

January 3, 2023 STAT Off 3 to watch, Biotech, Business, Congress, hospitals, Human Health, insurance, Life Sciences, Medicaid, Medicare, Medicine, physicians, Science and Research, STAT+, White House

For almost three years, hospitals and health insurers have been riding the waves of the…

December 27, 2019 STAT Off 3 to watch, Biotech, campaigns, Congress, drug pricing, Human Health, Life Sciences, Medicine, policy, Politics, Science and Research

WASHINGTON — Drug prices are on the ballot once again in 2020. It’s already evident…

December 26, 2019 STAT Off 3 to watch, Biotech, drug development, Health, Human Health, infectious disease, Life Sciences, Medicine, public health, Science and Research, vaccines

New Year’s Day may usher in a new decade, but our crystal ball suggests some…

December 26, 2019 STAT Off 3 to watch, Biotech, biotechnology, Business, drug develpment, Human Health, Life Sciences, Medicine, Science and Research

For biotech, 2019 ended like the penultimate episode of a prestige TV show. We got…

December 24, 2019 STAT Off 3 to watch, Biotech, Health Tech, Human Health, Life Sciences, Medicine, Science and Research

Judging by the numbers, digital health companies had another huge year in 2019. Total investment…